SMTL ID : 4fyo.1

Crystal structure of spleen tyrosine kinase complexed with N-{(S)-1-[7-(3,4-Dimethoxy-phenylamino)-thiazolo[5,4-d]pyrimidin-5-yl]-pyrrolidin-3-yl}-terephthalamic acid

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

monomer

Ligands

1 x 0VF: 4-{[(3S)-1-{7-[(3,4-dimethoxyphenyl)amino][1,3]thiazolo[5,4-d]pyrimidin-5-yl}pyrrolidin-3-yl]carbamoyl}benzoic acid(Non-covalent)

0VF.1: 20 residues within 4Å: Chain A: L.25, G.26, S.27, G.28, V.33, A.48, V.81, M.96, E.97, M.98, A.99, E.100, L.101, G.102, P.103, N.105, K.106, R.146, L.149, D.160 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.33, A:P.103, A:R.146 Hydrogen bonds: A:S.27, A:A.99, A:A.99, A:N.105 Water bridges: A:Q.109, A:R.146, A:N.147, A:S.159, A:D.160 Salt bridges: A:K.106

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lucas, M.C. et al., Rational design of highly selective spleen tyrosine kinase inhibitors. J.Med.Chem. (2012)

Release Date

2013-01-30

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence